(Total Views: 467)
Posted On: 09/16/2020 6:57:58 PM
Post# of 148899
I agree again peacekat.
Here is what I have to say about his call today:
" Yeah, some review of old stuff we know and the Drs., it was nice to hear even though we knew about the successes there but all in all, it just keeps getting better.
Hey everyone, Rome was not built in a day. Biotechnology takes a lot of time to get through approvals. I've listened to a lot of CC's about what the fda says and it does seem in a very, very weird that the fda does want to see forward progress and again, IMO, the fda is seeing something in Leronlimab that they have NEVER everr seen before so it's going to take more time for them to believe in the data they're seeing as no other drug approved or in preapproval status has ever shown the results that Leronlimab is showing to them. Ask yourselves, have you seen a molecule like Leronlimab before? Heck NO! And neither has the fda so take a break everyone and wait for it all to come to fruition.
As for Leronlimab passing through the blood brain barrier, that is something special to me. That opens up some very interesting possibilities for those who suffer from nerve problems etc. etc. Again I say that the fda has not seen this before from any company, LIlly, Merk, BMY, Regeneron or any others.
Yes tomorrow might be a bit ugly but if you are all truly long term investores, you have to see the big tree, (Leronlimab), through the forest.
IMO again, I don't care how long it takes for whats in store for us and the patients that will be helped by CYDY is totally revolutionary in medicine. When you have something that no other pharma or bio-tech has, do you expect it to be rushed through the regulators and agencies? I don't think so.
Once we get just one indication approved by any fda in or out of the USA, CYDY will be a name that no one will EVER forget so be patient for this to shall pass and pass the fda with colors - GLTU peacekat and all longs
HCIT
Here is what I have to say about his call today:
" Yeah, some review of old stuff we know and the Drs., it was nice to hear even though we knew about the successes there but all in all, it just keeps getting better.
Hey everyone, Rome was not built in a day. Biotechnology takes a lot of time to get through approvals. I've listened to a lot of CC's about what the fda says and it does seem in a very, very weird that the fda does want to see forward progress and again, IMO, the fda is seeing something in Leronlimab that they have NEVER everr seen before so it's going to take more time for them to believe in the data they're seeing as no other drug approved or in preapproval status has ever shown the results that Leronlimab is showing to them. Ask yourselves, have you seen a molecule like Leronlimab before? Heck NO! And neither has the fda so take a break everyone and wait for it all to come to fruition.
As for Leronlimab passing through the blood brain barrier, that is something special to me. That opens up some very interesting possibilities for those who suffer from nerve problems etc. etc. Again I say that the fda has not seen this before from any company, LIlly, Merk, BMY, Regeneron or any others.
Yes tomorrow might be a bit ugly but if you are all truly long term investores, you have to see the big tree, (Leronlimab), through the forest.
IMO again, I don't care how long it takes for whats in store for us and the patients that will be helped by CYDY is totally revolutionary in medicine. When you have something that no other pharma or bio-tech has, do you expect it to be rushed through the regulators and agencies? I don't think so.
Once we get just one indication approved by any fda in or out of the USA, CYDY will be a name that no one will EVER forget so be patient for this to shall pass and pass the fda with colors - GLTU peacekat and all longs
HCIT
(3)
(0)Scroll down for more posts ▼
